Incorporating Biometric Data for Patients Receiving Concurrent Chemotherapy & RT
{ "Observational Study of Wearable Health Technology in Cancer Treatment", "This study is looking at how well wearable health technology (WHT) can be used in a cancer clinic. WHT devices, like smartwatches, collect your health data such as heart rate and steps taken. The goal is to see if using these devices can help doctors and patients understand how treatment, like radiation therapy and chemotherapy, is affecting a patient's body. You would wear a WHT device throughout your treatment and for four weeks afterward, uploading the data at the clinic. This study is for adult cancer patients (18 years or older) who speak English and are receiving care at Novant-New Hanover Regional Medical Center.", "design": "This is an observational study involving 20 participants. It is not testing a new treatment, but rather how a new process (using wearable technology) works in a clinic setting.", "commitments": "You would wear a wearable health technology device throughout your cancer treatment and for 4 weeks afterward. You would also upload the data from your device onto computers at the clinic.", "compensation": "Not stated in the trial record.", "follow_up": "You will wear the device and upload data for up to 12 weeks, which includes your treatment period and 4 weeks afterward.", }
- Study design
- Not specified.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Not specified.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Incorporating Biometric Data for Patients Receiving Concurrent Chemotherapy & RT
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Lukasz Mazur, MD · PRINCIPAL_INVESTIGATOR · UNC Lineberger Comprehensive Cancer Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- The rate of technology adoptionUp to 12 weeks
The rate of technology adoption will be quantified as the fraction of subjects who successfully download their WHT data into the research databases in the radiation oncology clinic. Success, on a subject-specific basis, will be defined as their reporting any of their WHT biometric data on \>40% of eligible days.